関連する実験動画
Updated: Aug 9, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
髄膜球菌病による難治性心呼吸器不全に対する体外のサポート
A P Goldman1, S J Kerr, W Butt
1Great Ormond Street Hospital for Children, London, UK.
Lancet (London, England)
|February 15, 1997
まとめ
身体外膜酸素化 (ECMO) は,重度の髄膜球菌病と心肺機能不全の患者をサポートすることができます. この心臓肺機械療法は,標準治療に反応しない重症患者の生存のチャンスを提供します.
科学分野:
- 小児重症病棟医療 幼児重症病棟医療
- 心肺支援技術について
- 感染症 感染症は感染症です.
背景:
- 髄膜炎球菌疾患は,主に耐性心筋圧縮,低血圧,重度の急性呼吸器障害症候群による重大な死亡率を引き起こします.
- 身体外膜酸素化 (ECMO) は,心臓肺装置を使用して一時的な心臓および呼吸器のサポートを提供します.
- 本研究では, meningokoccal diseaseに対するECMOに関する英国とオーストラリアの経験をレビューしています.
研究 の 目的:
- 髄膜炎球菌疾患および耐性心肺衰竭の小児患者におけるECMOの有効性およびアウトカムを評価する.
- 重度の髄膜球菌感染症における救助療法としてのECMOの役割を評価する.
主な方法:
- イギリスとオーストラリアで1989年から2007年の間に髄膜炎球菌疾患のためにECMOを受けた12人の小児患者の遡及的レビュー.
- 患者の人口統計,ECMO (心不全と呼吸器不全) の用例,ECMO以前の介入,およびアウトカムに関する分析.
主要な成果:
- 12人の患者 (平均年齢26ヶ月) は,髄膜炎球菌疾患のためにECMOを受けた.
- 治療不可能なショックのために7人の患者が早期ECMOを必要とし,呼吸不全のために5人が後でECMOを必要とした.
- 12人の患者のうち8人は生存し,6人は追跡時に正常な生活を達成しました.
結論:
- ECMOは,治療不可能な心肺機能不全を経験している Meningococal疾患の小児患者にとって有効な選択肢です.
- ECMOの検討は,重症で治療に耐性のある髄膜球菌症例の生存率を改善する可能性があります.
関連する概念動画
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

